TL;DR
Get workout gear delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A study published in JAMA Cardiology found that people who later experienced a cardiovascular event had poorer frailty, intrinsic capacity and physical quality-of-life profiles than matched controls as far as a decade beforehand. The gaps widened in the five years before an event, but the findings show an association and do not establish that functional decline causes cardiovascular disease.
People who later experienced cardiovascular events had worse measures of frailty, intrinsic capacity and physical health-related quality of life than matched controls, with differences evident years beforehand, according to an analysis of 12,015 participants. Published online September 23 in JAMA Cardiology, the study found that the gaps grew more marked in the five years before an event. The findings suggest a potential period for closer clinical attention but do not show that functional decline causes cardiovascular disease.
Aung Zaw Zaw Phyo of Monash University in Melbourne and colleagues analyzed data from the Aspirin in Reducing Events in the Elderly cohort. The nested case-control study included 2,403 people who experienced a cardiovascular event and 9,612 matched controls. Researchers compared changes over time in multiple measures of function and aging before the event.
Compared with controls, participants who later had an event showed higher frailty, lower intrinsic capacity and poorer physical health-related quality of life in the years leading up to it. The study reported faster deterioration over time among cases, including increases in two frailty measures and declines in intrinsic capacity and physical quality of life. The report provides model estimates for these trends, but does not give units that would allow the coefficients to be read as straightforward changes in a clinical score.
The patterns were seen across components of the cardiovascular disease composite, though the timing varied. Differences appeared at least 10 years beforehand for heart failure and fatal coronary heart disease; for myocardial infarction and stroke, the report says the divergence occurred later. These findings describe differences between groups over time, not a test that can predict an individual person’s event.
A Longer Window for Clinical Attention
The findings may matter because cardiovascular risk is often considered in relation to established disease markers, while measures such as frailty and physical function describe how a person is doing across several aspects of health. The study suggests these measures may change well before a cardiovascular event becomes clinically apparent, potentially giving clinicians additional information to discuss alongside other risk factors.
The authors describe the pattern as a possible prolonged window for closer clinical evaluation and early intervention. That is an interpretation of observational findings, not evidence that monitoring these measures or intervening on them will prevent heart attacks, strokes, heart failure or deaths. The results also do not mean that functional decline by itself signals an impending cardiovascular event. Any practical use would require further research into how well these measures predict outcomes and what clinical response, if any, improves them.
frailty assessment tools for elderly
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How the Cohort Was Compared
The research, titled Multidimensional Aging Trajectories Preceding Cardiovascular Events, was published in JAMA Cardiology. It used a nested case-control design within the Aspirin in Reducing Events in the Elderly cohort, comparing participants who experienced cardiovascular events with matched participants who did not have an event during the relevant comparison.
The researchers examined several dimensions rather than relying on a single measure: frailty, intrinsic capacity and physical health-related quality of life. The source report describes trajectories leading up to events, with some differences visible up to a decade beforehand and widening in the final five years. It does not provide enough detail to treat the results as a population-wide screening recommendation or to determine an individual’s personal risk from a functional assessment.
“Declines in functional aging markers were prominent before clinically apparent CVD.”
— Aung Zaw Zaw Phyo and colleagues, in the study
Prediction and Cause Remain Unsettled
The study shows that functional decline and later cardiovascular events were associated in this cohort. It does not establish cause and effect, explain why the trajectories differed, or show that slowing functional decline would reduce cardiovascular events. The source report also does not provide information needed to judge how accurately these measures would predict events in people outside the study.
Other questions remain, including how the findings apply across different populations and whether the observed patterns persist after accounting for all relevant health differences. The report does not set out a clinical threshold, screening schedule or intervention based on frailty, intrinsic capacity or quality-of-life scores. The timing of divergence also differed by event type, so a single timeline should not be assumed for all cardiovascular conditions.
Testing Clinical Use in Further Research
The study establishes an association that further research can examine; the source material does not report a planned follow-up trial or a new clinical guideline. Future work would need to assess whether these functional measures add useful predictive information beyond established cardiovascular risk factors and whether acting on that information changes patient outcomes.
For now, the findings support attention to the distinction between an early warning pattern at group level and an individual diagnosis. Readers should not interpret ordinary changes in strength, activity or day-to-day function as proof of cardiovascular disease. Questions about declining function or cardiovascular risk are best discussed with a health professional, who can consider symptoms and the person’s broader medical history.
Key Questions
What did the study find?
People who later experienced cardiovascular events had worse frailty, intrinsic capacity and physical quality-of-life profiles than matched controls years beforehand. The differences widened in the five years before the events.
How many people were included?
The analysis included 12,015 participants: 2,403 who experienced a cardiovascular event and 9,612 matched controls from the Aspirin in Reducing Events in the Elderly cohort.
Does functional decline cause cardiovascular disease?
The study does not establish that. It reports an association over time between functional decline and later cardiovascular events, but cannot show that one caused the other.
Can these findings predict an individual’s risk?
Not on the evidence reported. The study describes group trajectories and does not provide a validated individual prediction test, clinical threshold or recommended screening schedule.
When did the researchers see differences before events?
Differences were present years ahead of events and widened in the final five years. For heart failure and fatal coronary heart disease, the report says divergence was visible at least 10 years beforehand; timing was later for myocardial infarction and stroke.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
